Study of the Safety and Effectiveness of Esmirtazapine in Participants With Chronic Primary Insomnia (P05706)
Clinical trial NCT00482612 · COMPLETED
Trial details
- NCT number
- NCT00482612
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-07
- Primary completion
- 2008-08-11
- Enrollment
- 526
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.